Cargando…

Implication of ultrasound bladder parameters on treatment response in patients with benign prostatic hyperplasia under medical management

OBJECTIVE: The prevalence of benign prostatic hyperplasia (BPH) rapidly increases after the 4th decade of life. The combination of tamsulosin and dutasteride is a well established therapy for BPH of ≥40 g. Non-invasive urodynamic parameters can predict the outcome of medical therapy in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thekumpadam Puthenveetil, Rajeev, Baishya, Debajit, Barua, Sasanka, Sarma, Debanga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Second Military Medical University 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730744/ https://www.ncbi.nlm.nih.gov/pubmed/29264151 http://dx.doi.org/10.1016/j.ajur.2015.08.004

Ejemplares similares

Unusual case of nephrocutaneous fistula – Our experience
por: Puthenveetil, Rajeev Thekumpadam, et al.
Publicado: (2016)

Giant adrenal tumor presenting as Cushing's syndrome and pheochromocytoma: A case report
por: Bagchi, Puskal Kumar, et al.
Publicado: (2015)

Correlation between differential renal function estimation using CT-based functional renal parenchymal volume and (99m)Tc - DTPA renal scan
por: Sarma, Debanga, et al.
Publicado: (2012)

Renal Transplantation Could Reverse Dialysis-Associated Porphyria
por: Barua, Sasanka k, et al.
Publicado: (2022)

Predictors of Progression-Free Survival and Overall Survival in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Single-Center Experience
por: Barua, Sasanka Kumar, et al.
Publicado: (2019)

Role of primary chemotherapy in management of large tumors of undescended testis: Our experience
por: Sarma, Debanga, et al.
Publicado: (2013)

Combining Prostate-Specific Antigen Parameters With Prostate Imaging Reporting and Data System Score Version 2.0 to Improve Its Diagnostic Accuracy
por: Baruah, Sasanka Kumar, et al.
Publicado: (2019)

Benign prostatic hyperplasia and subsequent risk of bladder cancer
por: Kang, D, et al.
Publicado: (2007)

Role of Diffusion-Weighted Magnetic Resonance Imaging (DWMRI) in Assessment of Primary Penile Tumor Characteristics and Its Correlations With Inguinal Lymph Node Metastasis: A Prospective Study
por: Barua, Sasanka Kumar, et al.
Publicado: (2018)

Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction
por: Patel, Nishant D., et al.
Publicado: (2014)

Risk factors for bladder calculi in patients with benign prostatic hyperplasia
por: Huang, Wei, et al.
Publicado: (2017)

Benign Prostatic Hyperplasia
Publicado: (2015)

Tamsulosin and Solifenacin in the Treatment of Benign Prostatic Hyperplasia in combination with overactive bladder
por: Wang, Hui, et al.
Publicado: (2017)

Prostatic anatomical parameters correlate with clinical characteristics suggestive of benign prostatic hyperplasia
por: Tian, Ye, et al.
Publicado: (2020)

Bladder stone secondary to prostatic urethral lift (PUL) for benign prostatic hyperplasia (BPH)
por: Kang, JiHun
Publicado: (2021)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Clinical application of contrast enhanced ultrasound to diagnose benign prostatic hyperplasia
por: Shi, Jingfang, et al.
Publicado: (2014)

Effect of Nocturia on Quality of Life among Clients with Benign Prostatic Hyperplasia
por: Varughese, Susamma, et al.
Publicado: (2021)

Comparison of Clinical and Physiological Parameters for Benign Prostatic Hyperplasia in Hypertensive and Normotensive Patients
por: Zeng, Xian-Tao, et al.
Publicado: (2018)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies
por: Dai, Xiaoyu, et al.
Publicado: (2016)

Acute urinary tract infection in patients with underlying benign prostatic hyperplasia and prostate cancer
por: Tolani, Musliu Adetola, et al.
Publicado: (2020)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Stimulation of prostate cells by the senescence phenotype of epithelial and stromal cells: Implication for benign prostate hyperplasia
por: Jiang, Shoulei, et al.
Publicado: (2019)

Retraction Note: Clinical application of contrast enhanced ultrasound to diagnose benign prostatic hyperplasia
por: Shi, Jingfang, et al.
Publicado: (2015)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Relationship of Postoperative Recatheterization and Intraoperative Bladder Distention Volume in Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia
por: Kim, Hyeon Jun, et al.
Publicado: (2013)

Modified bladder outlet obstruction index for powerful efficacy prediction of transurethral resection of prostate with benign prostatic hyperplasia
por: Liu, Hongming, et al.
Publicado: (2021)

Comparative RNA-sequencing analysis of the prostate in a mouse model of benign prostatic hyperplasia with bladder outlet obstruction
por: Tang, Xiaohu, et al.
Publicado: (2023)

Treating overactive bladder symptoms after transurethral prostatic surgery for benign prostatic hyperplasia – Which medication to choose?
por: Lee, Cheng-Ling, et al.
Publicado: (2023)

Bladder Tissue Microbiome Composition in Patients of Bladder Cancer or Benign Prostatic Hyperplasia and Related Human Beta Defensin Levels
por: Mansour, Bassel, et al.
Publicado: (2022)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0g03jfghvdjh5pmqarihq2k9c4